In this edition of Clinical Lab Chat, Director of Business Intelligence Chris Wolski discusses with Courtney Noah, PhD, VP of Scientific Affairs at BioIVT, how blood-based biofluid testing is poised to revolutionize cancer diagnostics.Among the topics they dig into are:The benefits of blood-based biofluid testing over traditional, more invasive methods.How biofluid testing saves money and improves access for patients.How labs can add blood-based biofluid testing onto their diagnostic menus.The importance of proper sample collection.The renaissance in the use of blood-based biomarkers in diagnostic testing.

Ver todos los episodios